SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-17-148114
Filing Date
2017-04-28
Accepted
2017-04-28 16:06:07
Documents
4
Period of Report
2017-06-15
Effectiveness Date
2017-04-28

Document Format Files

Seq Description Document Type Size
1 DEF 14A d367219ddef14a.htm DEF 14A 446384
2 GRAPHIC g367219g02k50gray.jpg GRAPHIC 14010
3 GRAPHIC g367219g99y44.jpg GRAPHIC 30556
4 GRAPHIC g367219pc02.jpg GRAPHIC 7568
  Complete submission text file 0001193125-17-148114.txt   519514
Mailing Address 85 WELLS AVENUE SECOND FLOOR NEWTON MA 02459
Business Address 85 WELLS AVENUE SECOND FLOOR NEWTON MA 02459 617-658-0600
Karyopharm Therapeutics Inc. (Filer) CIK: 0001503802 (see all company filings)

IRS No.: 263931704 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36167 | Film No.: 17795433
SIC: 2834 Pharmaceutical Preparations